KorrekturOpen Access · CC BY-NC-ND 4.0
Correction to: “Diazoxide Choline Extended-Release (DCCR) Use in Prader–Willi Syndrome: Patient Selection, Dosing, and Management”
Journal of the Endocrine Society · 03.06.2026 · 10 (7)
DOI: 10.1210/jendso/bvag144 ↗Kurz gefasst
Korrektur in der Zeitschrift Journal of the Endocrine Society, online erschienen am 01.07.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
[This corrects the article DOI: 10.1210/jendso/bvag099.].
Zitieren
APA
(2026). Correction to: “Diazoxide Choline Extended-Release (DCCR) Use in Prader–Willi Syndrome: Patient Selection, Dosing, and Management”. Journal of the Endocrine Society, 10(7). https://doi.org/10.1210/jendso/bvag144
Vancouver
Correction to: “Diazoxide Choline Extended-Release (DCCR) Use in Prader–Willi Syndrome: Patient Selection, Dosing, and Management”. Journal of the Endocrine Society. 2026;10(7). doi:10.1210/jendso/bvag144
BibTeX
@article{euvimed2026,
title = {Correction to: “Diazoxide Choline Extended-Release (DCCR) Use in Prader–Willi Syndrome: Patient Selection, Dosing, and Management”},
journal = {Journal of the Endocrine Society},
year = {2026},
volume = {10},
number = {7},
doi = {10.1210/jendso/bvag144}
}
EUVIMED